fda warning glp-1 november 2025 Diabetes advocacy group discourages use of compounded drugs FDA issued 25 warning letters

[1] [7] Other notable effects include injection site reactions beyond pain (erythema, pruritus, induration in 13% of patients), increased heart rate (particularly with liraglutide), gallbladder disease (including gallstones and cholecystitis), and potential dehydration-related acute kidney injury

Discussion DPP-4 inhibitors are effective and widely used therapeutics for type 2 diabetes

In many women, theyre addressing two separate problems at exactly the same time

Common Side Effects (Mild) Injection site discomfort Brief pinch during injection and occasional mild soreness for a few hours

TLDR: Peptide syringe sizes describe barrel capacity, such as 0.3 mL, 0.5 mL, or 1 mL